Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori

American Journal of Gastroenterology

Volumn 97, Issue 10, 2002, Pages 2536-2539

  Sullivan, Brian ^a,b   Coyle, Walter ^a   Nemec, Richard ^a   Dunteman, Thomas ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BISMUTH; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DYSGEUSIA; ERADICATION THERAPY; FATIGUE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; AZITHROMYCIN; BISMUTH; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; OMEPRAZOLE; PROSPECTIVE STUDIES; STOMACH DISEASES;

EID: 0036791678     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04394-0     Document Type: Article

References (22)

1. NIH Consensus Statement. Helicobacter pylori in peptic ulcer disease. JAMA 1994;12:1-23.
2. American Digestive Health Foundation. International update conference on Helicobacter pylori. Gastroenterology 1997;113(Suppl 6):54-8.
3. Howden C, Hunt R. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol 1998;93:2330-8.
4. Ellenrieder V, Boek W, Richter C, et al. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol 1999;34:750-6.
5. Osato M, Reddy R, Graham D. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int J Antimicrob Agents 1999;12:341-7.
6. Alarcyon T, Domingo D, Lyopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents 1999;12:19-26.
7. Blandizzi C, Malizia T, Gherardi G, et al. Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis. J Antimicrob Chemother 1998;42:75-82.
8. Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: A controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996;91:258-63.
9. Di Mario F, Dal Bo N, Grassi S, et al. Azithromycin for the cure of Helicobacter pylori infection. Am J Gastroenterol 1996;91:264-7.
10. Caselli M, Trevisani L, Tursi A, et al. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1997;9:45-8.
11. Chey W, Fisher L, Barnett J, et al. Low versus high dose azithromycin triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998;12:1263-7.
12. Trevisani L, Santori S, Galvani F, et al. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease. Aliment Pharmacol Ther 1998;12:1269-72.
13. Vcev A, Stimac D, Takac B, et al. High dose omeprazole plus amoxicillin and azithromycin in eradication of Helicobacter pylori in duodenal ulcers. Helicobacter 1999;4:54-7.
14. al-Assi M, Genta R, Karttunen T, et al. Azithromycin triple therapy for Helicobacter pylori infection: Azithromycin, tetracycline, and bismuth. Am J Gastroenterol 1995;90:403-5.
15. Vcev A, Vceva A, Stimac D, et al. Omeprazole, azithromycin and either amoxicillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients. Aliment Pharmacol Ther 1998;12:453-6.
16. Vcev A, Stimac D, Ivandic A, et al. Pantoprazole, amoxicillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients. Aliment Pharmacol Ther 2000;14:69-72.
17. Laurent J, Megraud F, Flejou J, et al. A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2001;15:1787-93.
18. Trautman M, Riediger C, Moricke A, et al. Combined activity of azithromycin and lansoprazole against Helicobacter pylori. Helicobacter 1999;4:113-20.
19. Graham D, deBoer W, Tytgat G. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-6.
20. Chey W, Fisher L, Elta G. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacrer pylori infection: A randomized trial. Am J Gastroenterol 1997;92:1483-7.
21. Krickhoff R, Laufen H, Schacke G, et al. Determination of azithromycin in gastric biopsy samples. Int J Clin Pharmacol Ther 1999;37:361-4.
22. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Eng J Med 2001;345:784-9.